Forbion raises €2.3B, becomes largest European biotech investor

Forbion, a Dutch biotech investment firm, raised €2.3 billion in its latest fund, increasing its total assets under management to €7.5 billion. This follows a €2.1 billion raise two years ago, marking a significant expansion in European biotech venture capital. The move signals sustained investor appetite for biotech innovation in Europe, though the specific deployment strategy remains undisclosed.